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Matrix processing peptidaseX-ray crystal structures of bc1 complexes obtained over the last 15 years have provided a ﬁrm structural basis
for our understanding of the complex. For the most part there is good agreement between structures from
different species, different crystal forms, and with different inhibitors bound. In this review we focus on
some of the remaining unexplained differences, either between the structures themselves or the interpreta-
tions of the structural observations. These include the structural basis for the motion of the Rieske iron–sulfur
protein in response to inhibitors, a possible conformational change involving tyrosine132 of cytochrome
(cyt) b, the presence of cis-peptides at the beginnings of transmembrane helices C, E, and H, the structural
insight into the function of the so-called “Core proteins”, different modelings of the retained signal peptide,
orientation of the low-potential heme b, and chirality of the Met ligand to heme c1. This article is part of a
Special Issue entitled: Respiratory complex III and related bc complexes.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
In the last two decades crystal structures have become available
for bc1 complexes from vertebrates, yeast, and α-proteobacteria;
and b6f complexes from chloroplasts and cyanobacteria. What have
they told us? Reassuringly, they did not reveal any features incompat-
ible with the “modiﬁed Q-cycle” mechanism for coupling proton
pumping to electron transfer, which had been pretty well adopted
by the time of the ﬁrst structures. Two inhibitor-binding sites were
identiﬁed corresponding to the QN and QP sites located on opposite
sides of the membrane near the bH and bL hemes respectively. The b
hemes provide a path for electrons between the sites, as inferred
from the “double kill” experiments [1,2] and required by the Q cycletes of the bc complex near the
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l rights reserved.mechanism. The structures mainly conﬁrmed the picture that had
been built up from years of theorizing, biophysical experimentation,
site-directed and inhibitor-resistant mutagenesis, and bioinformatics
[3,4]. One surprise was the requirement for movement of the Rieske
iron–sulfur protein (ISP) for electron transport from the QP site
to cyt c1, opening up new possibilities for gating to enforce the bifur-
cated reaction. Another stimulating result is the fact that the heme bL
moieties in the two monomers are within effective electron transfer
distance on a kinetically competent time scale, leading to questions
about the importance of inter-monomer electron transfer. Both b
hemes are close to their respective membrane surfaces, consistent
with reactivity with water soluble reagents [5] but leaving unex-
plained the apparently large electrogenic step for electron transfer
between heme bH and quinone at the QN site. Perhaps the biggest
disappointment is that no reliable structure for quinone or quinol at
the QP site has been obtained. Thus the structures have not contribut-
ed as much as might be expected to explaining the mechanism of the
bifurcated reaction. But it seems reasonable to assume that quinone
binds (for at least part of the reaction) in the position of stigmatellin
or nHDBT, with an H-bond to a ligand of the Fe2S2 cluster. By provid-
ing accurate position of the redox centers including the ISP cluster in
multiple positions, the structures provide distances between redox
centers. These, together with extensive kinetic data mainly from
ﬂash-activated experiments in the photosynthetic systems, strongly
constrain the type of mechanisms that can be considered [6].
Crystal structures of the bc1 complex have been obtained from
seven crystal forms of the mitochondrial complex, from beef, chicken,
and yeast; and four forms of the bacterial complex, from two species
of Rhodobacter and Paracoccus denitriﬁcans. Cytochrome b6f structures are
available from two additional crystal forms. Table 1 lists the different
Table 1
Different crystal forms of the cytochrome bc1 and b6f complexes that have provided structures.
Source Space
group
Ref. Examples bc1/AU Best
resolution
ISP-EDa






I4122 [7] 1qcr, 2fyu 1 2.3 m N Y
P6522 [8,9] 1be3 1 3.0 c1 N Y
P65 [9] 1bgy 2 3.0 (2.5b
)
I, m N Y
P212121 [10] 1ppj, 2a06 2 2.1 b, b Y N
Chicken
P212121 [8] 1bcc, 3h1h, 3L70 2 2.7 m, m Y N
Yeast
C2 [11] 1ezv, 1kb9, 1p84 1 2.3 b N N
P21 [12,13] 1kyo, 3cx5 2 1.9 b,b Y N
Rb. caps.
P21 [14] 1zrt 2 3.5 b Y na
Rb. sph.
C2 [15,16] 2fyn, 2qJk, 2qJy 6 2.4 b Y N
P21 [16] 2qJp 4 2.6 b Y N
Pc. deni.
P21 [17] 2yiu 2 2.7 Y na
Chlamy.
I222 [18] 1q90 1 3.1 Y
Mastigo.,
Nostoc P6122 [19] 2e74, 2zt9 1 3.0 Y
a Position or state of the ISP extrinsic domain. “Mobile” implies the ability to move in the crystal, although it may be ﬁxed in b or c1 position in particular structures, especially in
the presence of inhibitors. “I” refers to an intermediate position seen in one monomer of structure 1bgy.
b Resolution in parentheses is unpublished but reported at meetings or otherwise known.
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forms has been very beneﬁcial, as the different forms tend to have differ-
ent areas well-ordered or disordered, and so complement each other in
providing a complete structure of the protein.
The highest resolution (1.9–2.4 Å) structures have come from the
yeast P21 and C2 crystals, bovine orthorhombic (P212121) and tetrag-
onal (I4122) crystals, and Rhodobacter sphaeroides C2 crystals. Some
crystal forms lack one small peripheral subunut: subunit 11(verte-
brates) or QCR10 (yeast), and subunit 4 in R. sphaeroides. Since
these subunits are not required for activity this probably does not
detract from the usefulness for explaining function.
As mentioned above, the extrinsic domain of the Rieske ISP is found
in different positions in different structures. Fig. 1 compares the ISP ex-
trinsic domain's position and orientation in structures from each of the
crystal forms with that of the beef tetragonal crystals in the presence of
stigmatellin. Two crystal forms, the chicken orthorhombic (P212121)
and beef tetragonal, have an unfettered ISP allowing different positions
or states of mobility to be observed in the same crystal form. Most of
the highest resolution crystal forms have been obtained only with
stigmatellin or similar inhibitor bound, which locks the ISP extrinsic
domain in the “b” position. This precludes looking at different positions
or mobility states (except by comparing these structures with those in
other ISP states) or binding of QP inhibitors that do not maintain the b
position. For example both yeast crystals are obtained with the aid of
an anti-ISP Fv fragment which is intimately involved in crystal packing,
and probably contributes to the good order and high resolution of these
crystals [20]. The disadvantage is that presumably these crystals cannot
be formed except when the ISP is in the b position. On the other hand
the P6522 beef crystal's crystal contacts involve the ISP in the c1 position
(Fig. 2), so these crystals cannot be formedwith inhibitors that hold the
ISP in the b position. Table 1 indicateswhich crystals have the ISP locked
in the b or c1 position andwhich have demonstrated potential for differ-
ent positions.
Another important characteristic tabulated is non-crystallographic
symmetry, or the contents of the asymmetric unit. The bc1 complex
apparently always exists as a dimer (homodimer of heteromultimeric
protomers), and shows no tendency to monomerize except under
conditions of extreme detergent concentration and ionic strength
[21]. Any procedure to monomerize it is likely to destroy activity, asthe ISP has its transmembrane helix associated with one monomer
but functions with the other. An important question, which structures
may help to answer, is whether cooperation between the dimers is
important for function. When the enzyme crystallizes in a space group
with proper two-fold crystallographic symmetry (such as P6522,
I4122, or C2) the dimer axis is likely to be located on a crystallographic
2-fold so that the two monomers are crystallographically identical, i.e.
the asymmetric unit of the crystal contains amonomer.When it crystal-
lizes in a space group with no proper 2-fold (such as P65, P21, P212121)
then the 2-fold dimer symmetry becomes noncrystallographic and an
independent structure is obtained for each monomer. If in fact there is
asymmetry in the dimer then this is very important, not only because
it lets you observe both structures, but because if crystallized with a
monomer in the asymmetric unit, the asymmetric features would be
averaged out in the single resulting electron density, making the inter-
pretation difﬁcult. To the extent that the dimer is symmetric, having a
dimer still helps by increasing the ratio of data to parameters, since
the number of unique reﬂections is proportional to the size of the asym-
metric unit, while noncrystallographic constraints or restraints reduce
the parameters by nearly half or serve as additional data, respectively.
Crystals with more than one copy of the protomer in the asymmetric
unit include the yeast p21, bovine orthorhombic, chicken orthorhombic,
and beef P6 crystals (2 copies each) and R. sphaeroides P21 (4 copies) or
C2 (6 copies!) crystals.
Availability of the diffraction data is a very important attribute of the
structures because it allows those using the structure to make density
maps for examining the reliability of features that may not have been
described in the publication or for resolving conﬂicts between different
models. The deposited pdbﬁle is the crystallographer's interpretation of
the electron density, further regularized and improved by a reﬁnement
program. In some places the interpretationmay be absolutely clear and
one can make out every atom, but in some parts of most structures
the density is very unclear and the model is little more than the
crystallographer's best guess as to how the protein may go. Further-
more crystallographic reﬁnement techniques are steadily improving,
and it is likely that applying new techniques to old data will provide
new information about the structure and its dynamics. Already a project
is underway to re-reﬁne all of the structures in the PDB for which data is
available, using today's best-practices methodology [22]. Since Feb 2008
Fig. 1. Positions of the ISP extrinsic domain in different crystal structures. The position
of the Fe2S2 cluster and the orientation of the extrinsic domain were compared to
those in the presence of stigmatellin (structure 1sqx) to provide a 2-dimensional clas-
siﬁcation of the positions. Circles are from structures with no added inhibitors. Squares
represent structures with stigmatellin, HQNO, nHDBT, or hydroxynapthoquinone. Dia-
monds are structures with famoxadone, fenamidone, or JG144. Triangles are in the
presence of MOA-type inhibitors or triazolone compound. Color indicates the crystal
forms: red, beef orthorhombic; orange, beef tetragonal; green, chicken; blue, yeast
(two crystal forms). For the beef tetragonal crystal structures which contain a mono-
mer in the asymmetric unit, the dimeric “biological unit” was generated using crystal-
lographic symmetry. The structures were then superposed based on cyt b in one
monomer before making the comparisons.
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which structures are based, but many important bc1 structures predate
that requirement, and data is not available for some. It is to be
hoped that the authors will eventually go back to ﬁnd that data and
send it in to the PDB, which will greatly enhance the usefulness of
their deposition in the future.
For the most part the structures are in good agreement. It is
amazing how little the catalytic subunits, excluding peripheral
loops with ﬂexibility or insert/deletions, differ between bacteria,
fungi, and vertebrates. Even cyt b6 + subunit IV of the b6f com-
plexes is very similar to cyt b, especially on the P side of the mem-
brane. Our purpose here is to focus on the differences between the
structures, and on unexplained features. In some cases there are
real differences that can tell us something, and in other cases it is
just not clear what the true situation is. It is nice when several crys-
tals corroborate the same story, but we actually can learn morewhen
they differ, perhaps telling different parts of the same story. In other
cases the situationmay still not be clear in any of the crystals, and we
should be aware of the uncertainty. It is important to knowwhat you
don't know! Of course there are many unanswered questions about
the bc1 complexes, so we have had to be selective and cover a few
topics, mainly structural, where we are in as good a position asanyone, not to provide answers, but to provide some insight on the
problems.
2. Questions about the mobility of the Rieske iron–sulfur protein
Asmentioned above, the ISP is found in different position in different
structures. Fig. 1 demarcates the different positions in a 2-dimensional
plot, comparing the position in each structure with that in the tetragonal
crystal in the presence of stigmatellin (1sqx). Some of the variability
depends on the crystal form being used, and may reﬂect mainly crystal
packing forces operating on the intrinsic mobility of the ISP. More signif-
icantly, in two different crystal forms in which the ISP is free to move, its
extrinsic domain can be found in different positions, depending upon
what is present in the QP site. These are the tetragonal (I4122) crystals
of the bovine complex [7], and the orthorhombic (P212121) crystals of
the chicken complex [8]. However results from these two crystal forms,
while not contradictory, are somewhat different and have led to different
paradigms to describe the mobility of the ISP extrinsic domain: the
two-position model (distal/proximal or b/c1 positions [8,23,24]) vs one
based on occupancy (ﬁxed, vs released or mobile, states [15,25,26])
from the tetragonal crystals.
The differences between observations with the bovine tetragonal
crystals and the chicken orthorhombic crystals can be outlined with
three questions. One thing is the same — the position of the ISP in the
presence of stigmatellin or UHDBT is not signiﬁcantly different in
crystals of chicken, bovine, yeast, or bacterial bc1 complex in different
crystal forms. In other words, when the complex is in the ﬁxed state
induced by these or a few other inhibitors, the ISP is ﬁxed in the
same b position, regardless of the crystal form. So the ﬁrst question,
(1) “How do these inhibitors induce this position?” is not really a differ-
ence between crystals, but the way the results have been explained
using the two forms. Thiswill be considered in Section 2.1 below. A sim-
ilar question applies to the ﬁxed position induced by famoxadone and
related inhibitors, which is signiﬁcantly different from the b position
(Fig. 1) and so might require a different explanation (Section 2.2).
(2) When the ISP is not in the b position or ﬁxed state, the situation
depends very much on the crystal form. In structures from the beef te-
tragonal crystals the ISP is modeled with the cluster ~4 Å away from its
position in the b position, in what might best be called the “low-afﬁnity
ﬁxed position”. The occupancy (as judged by the anomalous peak due to
iron) is low, so this represents a minority of the unit cells in which the
ISP is in this position. The majority is really released, spread out over a
continuum of different positions without enough occupancy in any
one position to be crystallographically observable.
In several other crystals, the ISP is in adeﬁnedpositionwith the cluster
locatedwithin rapid electron transfer distance of cyt c1. What is respon-
sible for stabilizing the different c1 positions, and which if any of these
positions is relevant for the enzyme in the native membrane? And if
there is a true c1 position, why is it not seen in the tetragonal crystals?
These will be considered in Section 2.3 below.
Finally, (3)what is the position/state in the absence of any inhibitor?
In the chicken crystals it is the c1 position, and is essentially unchanged
when inhibitors favoring the c1 position are added, but moves to the b
position when inhibitors favoring that position are cocrystallized or
soaked in. In the tetragonal beef crystals it is in the ﬁxed position
(although at low occupancy) and moves to the low-afﬁnity ﬁxed posi-
tion, with even lower occupancy, upon binding of MOA inhibitors by
the complex. This will be discussed in Section 2.4 below.
2.1. How do inhibitors hold the ISP extrinsic domain in the “ﬁxed state”
or “b position”?
The position seen in the ﬁxed state of the tetragonal crystals (with
stigmatellin or nHDBT) is essentially identical to the b position of the
chicken crystals, and to the position seen in all other crystal forms
with stigmatellin(yeast, bacterial) or nHDBT(yeast, bovine), as can be
Fig. 2. Crystal contacts ﬁx the ISP position in the hexagonal (P6522) crystals. The principle inter-dimer contact is between the ISPs (blue) of one dimer and the core proteins of two
other dimers (yellow). As a result changes in cell parameters due to dehydration or freezing result in slightly different positions for the Fe2S2 cluster. The asymmetric unit contains a
monomer, so the two contacts depicted are identical by crystal symmetry, seen from opposite sides. Structure 1be3 was used for this ﬁgure. Figure made with O [88].
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stigmatellin (3h1j), a Crocacin D analog(3cwb), or ascochlorin (3h1L),
and in unpublished low-resolution structures (Huang and Berry) with
alkylhydroxynapthoquinones and UHDBT. Thus there is good agree-
ment about the structure in this state; the question is, how is it induced
by these inhibitors?
Theremay be a link between themechanismof these effects and the
enforced bifurcation of electron transport at the QP site. The ﬁxed state
is presumably the state in which the ISP cluster is reduced by quinol at
the QP site. This being the case, allowing or preventing binding in this
position presents an attractive possibility for gating the reaction at QP
to enforce bifurcation of electron transfer [15,25,27]. The different states
seen with different inhibitors have been suggested to reﬂect the states
in different stages of the reaction, allowing or preventing electron
exchange with the occupant of QP [15].
Since the ﬁrst detection of different positions or mobility states of
the ISP, there have been two different explanations. They are not
mutually exclusive, and perhaps neither can by itself explain all the
phenomena. Zhang et al. [8] pointed out the H-bond between
stigmatellin and the ISP cluster-ligand His161, and suggested this
was responsible for the b position in the presence of this inhibitor.
Fig. 3 shows this H-bond in structure 3h1j. The theory was further
developed by Crofts and coworkers [28]. The ISP extrinsic domain is
seen as freely diffusing within the limits of its tether, visiting different
sites and occupying them in proportion to their stability, or binding
constant. An H-bond from inhibitor to His161 was also seen with
other inhibitors promoting the b position: nHDBT (1p84, 1sqv) and
crocacin (3cwb). Inhibitors that promote the released state or c1
position (myxothiazol, MOA-stilbene and other MOA inhibitors)bind more proximally in the QP site and do not come within H-bonding
distance of, or project an H-bond donor or acceptor toward, the position
of the docked ISP. The energy to break an H-bond varies, but a typical
value is 5 kcal/mol, which is enough to make a 4000-fold change in an
equilibrium constant. Thus formation of this bond when the ISP is in
the b position could shift the equilibrium from the c1 position to b
position.Without the inhibitor the bond is not made, and the b position
is less stable by this same factor.
In the same year, Kim et al. [25] proposed that conformational
changes in the surface of cyt b, resulting from binding different
QP-site inhibitors, were responsible for ﬁxing the ISP in its
docking site or releasing it in the mobile state. Further evidence for
this came in 2002 when structures with an inhibitor of a new class
was determined [29]. This was famoxadone, and it resulted in ﬁxing
the ISP at high occupancy near the b position, but did not form an
H-bond with, or interact directly with, the ISP. A later, higher resolu-
tion structure from the same group (2fyu) with the structurally
similar inhibitor JG-144, conﬁrmed this ﬁxation without H-bond, as
did later structures with famoxadone and fenamidone in the chicken
crystal form (3L74, 3L75).
We have argued [24] that the situation with these inhibitors is dif-
ferent from that with stigmatellin: famoxadone results in a signiﬁcantly
different position from the b position seen with stigmatellin or nHDBT,
and while there is no H-bond from the inhibitor to the ISP, there is an
H-bond from Y279 in cyt b to the same cluster-ligand His161 involved
in the H-bond with b-position inhibitors. Still, the famoxadone-type
inhibitors demonstrate that the ISP can be ﬁxed near the b position in
the absence of an H-bond from inhibitor to the ISP, and it is difﬁcult
to exclude that whatever is responsible for the position with these
Fig. 3. Stereo view of stigmatellin in the QP site with the ISP docked in the “b” position. In structures with stigmatellin (shown here, central molecule with white bonds) or nHDBT,
the ISP is in the “b” or ﬁxed position, and there is a hydrogen bond between the inhibitor and cluster ligand His161 of the ISP. According to one hypothesis this H-bond is the factor
which stabilizes the b position in the presence of stigmatellin. Cyt b is colored green except the ef-helix (blue) and PEWY segment (ball and stick with blue bonds). The ISP is in
orange tubes with selected residues as ball and stick and the cluster as large balls. Note that the cluster is at a tip of the protein, surrounded by three “cluster bearing loops” of
protein. All three loops contact cyt b in the b position, although most of the contacts are not shown here. Only loop 1 contacts cyt b in the c1 position, as described in Section 2.3.
bH — high potential heme b. bL — low potential heme b. From structure 3h1J. Figure made with Molscript [89] and Raster3D [90]. Stereo pairs for cross-eyed viewing are available in
the supplemental materials for this and Figs. 6 and 10.
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H-bond. However we feel there is good evidence for a predominant
role of the H-bond in ﬁxing the position in other cases, as described
below. Famoxadone and related inhibitorswill be taken up as a separate
case in Section 2.3.
Three further papers [29,26,15] explored the conformational
changes in cyt b that seemed to correlate with mobility state of theFig. 4. Topology diagram showing the secondary structure elements of cytochrome b. Transm
with small letters corresponding to the transmembrane helices between which they occur.
involved in the QP site (orange), QN site (pink), and the “vise” which clamps the neck of thISP, and inhibitors which promote those states, classiﬁed as Pf favoring
ﬁxed state and Pm favoring the mobile state, in order to deﬁne the
conformational switch. Large side chain differences in the ef loop resi-
dues 252–255 reported in Table 2 of the earlier paper [29], and explored
by mutagenesis and ruthenium ﬂash kinetics [30], were not conﬁrmed
by other crystal forms or by later, higher resolution structures from
the same crystal form (e.g. compare 2fyu with 1ntm or 1ntz).embrane helices are named with capital letters A–H. Other helices and loops are named
Residue numbers correspond to the chicken sequence. Shaded areas indicate residues
e ISP, just below its hinge region, between the two monomers of cyt b (blue).
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tarity [31] to quantify changes in intimacy of the contact, but did not dis-
cuss differences in position of the ISP. The authors pointed out signiﬁcant
changes in conformation of cyt b in the PEWY sequence of the ef loop and
in the cd1 helix (The nomenclature of secondary structure elements is il-
lustrated in the topology diagram for cyt b in Fig. 4). The former change
was seen as not correlating with the type of inhibitor, andwas attributed
to widening of the QP pocket to accommodate either type of inhibitor.
Movement in the cd1 helix does correlate with the class of inhibitor,
with Pf inhibitors displacing it in the proximal direction, and Pm distal,
compared to the “native” structure. The cd1 helix thus seems to be the
best candidate for a conformational change gating the approach of the
ISP extrinsic domain to its docking position at the QP site.
Fig. 5 illustrates the movement of the cd1 helix, comparing structures
with azoxystrobin, a Pm inhibitor, and stigmatellin, a Pf inhibitor, after
superimposing the rigid transmembrane helices of cyt b. It can be seen
that the cd1 helix and the ﬁrst cluster-bearing loop of the ISP, which is
in contact with the cd1 helix, move together in the same direction by
about the same amount. More quantitatively, the Ca atoms of residues
142 in the ISP and 145 in the cd1 helix, which contact each other, move
by 2.95 and 2.33 Å, respectively. The directions of their movement differ
by only 14°. This gives the appearance that the cd1 helix is being pushed
down by the docking ISP or that it is moving down and allowing the ISP
to follow, rather than moving aside and allowing the ISP to fall into theFig. 5. Correlated movement of the ISP and the cd1 helix. Does the iron–sulfur protein
push the cd1 helix down upon docking, or does the cd1 helix move downward to pro-
vide a favorable docking surface for the ISP? Comparing structures with stigmatellin
(1sqx, yellow) and azoxystrobin (1sqb, blue) shows correlated movement between
the ISP and the cd1 helix. The view is a slab through the bovine bc1 complex showing
the interaction of the ISP with the cd1 helix. The orientation is from the opposite side as
Fig. 3, so cluster-bearing loop 1 which contacts the cd1 helix is on the right of the
cluster. The protein is shown as Cα traces, with thin sticks for the ISP and balls and
thick sticks for cytochrome b. The structures are aligned based on the transmembrane
helices of cyt b, some of which are partly shown. When this is done the cd helices and
the tip of the ISP are seen to be in different positions in the two structures. The Fe2S2
cluster (green and yellow spheres), His161, and stigmatellin (stg) are shown only for
the stigmatellin-containing structure. The double-headed white arrow indicates the
distance between Cα's of residue 147 in the cd1 helix and residue 126 in transmem-
brane helix C (residues 146 and 125 in beef), which we use to monitor position of
helix cd1 in the different structures. Note that cluster-bearing loop 1 of the ISP (just
right of the cluster) moves nearly the same as the cd1 helix maintaining some of the
contacts between them. Figure made with O [88].binding crater as suggested by the schematic in Fig. 3 of [15]. For other
views of this motion see Fig. 8 of [24], Fig. 2a of [15], and Fig. 5 of [32].
Unfortunately with the structures now available there is no way to
tell whether (1) the cd1 helix moves because of the inhibitor in the QP
site, and allows the ISP to move closer; or (2) the ISP is docking for
some other reason and exerting pressure on the cd1 helix which causes
it to move. Since the position of the ISP by deﬁnition correlates with the
Pf/Pm status of the inhibitor, any conformational change in cyt b that
correlates with the inhibitor status also correlates with the ISP position.
Thus it is impossible to say whether the conformational change results
from the inhibitor, or from the position of the ISP.
Comparing the structures with stigmatellin and azoxystrobin more
carefully, it is seen that the movement in the ﬁrst cluster-bearing loop
of the ISP is a little greater than that of the cd1 helix, making the contact
tighter in the stigmatellin structure. For example Leu142 of the ISP and
Asn148 (149 chicken) in the cd1 helix make an H-bond of 2.8 Å in the
stigmatellin structure, but 3.4 Å in the azoxystrobin structure. This
seems more consistent with the ISP bearing down on the cd1 helix in
the stigmatellin structure and easing up in the azoxystrobin. However
the Azoxystrobin structure is, after all, the released or low-afﬁnity
structure, and we cannot exclude that the cd1 helix pushes the ISP
a short distance, then other contacts break and the ISP rests loosely
on the cd1 helix or even diffuses away resulting in the low occupancy.
The movement of the cd1 helix could be a passive part of the “spring
loading” discussed in the next section, or it could be an active trigger
to break whatever attractions are holding the ISP in its crater.
In the chicken bc1 crystals, the same c1 position is seen in the
absence of inhibitors and with MOA inhibitors. And in this position
there is no contact between the extrinsic domain and the cd1 or cd2
helices. So if the movement of the cd1 helix is a result of pressure from
the ISP, then adding MOA inhibitors should not induce any movement
in the cd1 helix in these crystals. That is in fact the case (Fig. 6 of ref
[24]; compare native structures 3H1H, nt2, ant08a ~11.7 vs 11.5 Å for
chicken or beef tetragonal crystals with MOA inhibitors 3L70 or 1sqb),
but the argument is weakened by the fact that we don't fully understand
the difference between the native state in the chicken vs tetragonal beef
crystals, as discussed below in Section 2.4. If the native chicken crystals
display the c1 position because they are already in the MOA-induced
state in the absence of inhibitor, then it could be argued that the cd1
helix is already in its MOA-induced state. Still, this point is at least
compatible with the ISP driving the cd1 helix, whereas if we saw
MOA-inhibitor-induced movement of the cd1 helix in the absence
of ISP contacts, it would be a strong argument for the inhibitor
driving the cd1 helix movement.
In principle, if we could prevent the ISP from interactingwith the cd1
helix at all, and look for movement in that helix induced by inhibitors,
we should be able to answer the question. Experimentally this could
be approached in at least three different ways. We could use a disulﬁde
link to hold the ISP in the c1 position as in ref [33], we could use a crystal
form such as the P6522 crystals where the ISP is constrained in the c1
position by crystal contacts, or we could use an ISP-depleted complex
with a functional QP site, which is available for the bovine [34–36],
the Rhodobacter capsulatus [37,38], and perhaps yeast [39,40] bc1
complexes.
In practice this is foiled by the extremely low afﬁnity of the bc1
complex for Pf-type inhibitors stigmatellin [36] and famoxadone in
the absence of the ISP. This makes sense if you consider that the
inhibitor-ISP complex is an analog of the substrate or product com-
plex of the QP reaction, which seems reasonable at least in the case
of stigmatellin or nHDBT. The phenomenon we are investigating,
that binding of stigmatellin promotes movement of the ISP to the b
position, is just an embodiment of the formation of that complex.
The ﬂip side is that movement of the ISP to the b position promotes
tight binding of stigmatellin. Presumably many futile visits of each
occurs before they arrive together and lock into the complex. In the
case of stigmatellin, the obvious connection seems to be the H-bond:
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and stigmatellin binding forms an H-bond that holds the ISP in that
position. However since the same “mutual stabilization” occurs with
famoxadone which does not form an H-bond, we are made to realize
that the same thing could be achieved conformationally: If binding of
either partner requires the same conformational change in cyt b, the
energy required to induce that change would detract from binding
energy. Binding of either would then promote binding of the other,
and binding energy of both might be required to provide the energy
requirement of the conformational change.
Although this blocks one path for answering the question, it provides
us with a useful argument for testing residues for involvement in the
capture of the ISP: any mutation which prevents the ISP from moving to
the b position in the presence of stigmatellin or famoxadone would be
also expected to prevent tight binding of the inhibitor, since that requires
interaction with the ISP, presumably in the position normally induced by
the inhibitor. We will use this in discussing yeast mutants where we do
not have crystal structures with the inhibitors, to conclude that if the
inhibitor still binds tightly, the mutation has not eliminated the mutual
stabilization and thus the ability of the inhibitor to induce the ﬁxed state.
In the case of stigmatellin, and nHDBT there is a strong body of
indirect evidence that the H-bond between the QP-site occupant and
His161 is the predominant force ﬁxing the b position. This is based on
the dependence of several phenomena on the redox state of the ISP.
These arguments depend on the observation from high resolution
structures of the ISP fragment [41] that there is no signiﬁcant change
in the protein structure with redox state of the cluster.3 On the other
hand there is very good evidence now that protonation state of
His161 is redox-dependent, and so the strength of any H-bond formed
with that residue may depend on the redox state of the cluster.
One such argument involves the effect of the inhibitor stigmatellin
(or to a lesser extent nHDBT) on the Em of the ISP. It has long been
known that stigmatellin raises the midpoint of the ISP cluster by as
much as 250 mV [42], with the result that addition of stigmatellin
to the bc1 complex leads to reduction of the ISP, even in the absence
of any obvious reductant [43]. The classic explanation is that
stigmatellin binds to the bc1 complex about four orders of magnitude
more tightly when the ISP is reduced. Knowing that the binding site
for stigmatellin is in cyt b, with the only contribution of the ISP
being the H-bond, and assuming no redox-linked structural changes
in the protein, the simplest explanation is that the H-bond between
stigmatellin and the reduced ISP is stronger by ~6 kcal/mol than the
H-bond with the oxidized ISP (or if the H-bond with the oxidized
ISP does not form, that ΔG for formation of the bond with the reduced
ISP is ~6 kcal/mol). In the ISP depleted complex, stigmatellin binds
very weakly if at all [36]. Putting these together with the fact that
we are trying to explain, that in the presence of stigmatellin the ISP
is found in the b position, it seems likely that all three phenomena
(effect of stigmatellin on the midpoint potential, effect of stigmatellin
on the ISP position, and effect of ISP on stigmatellin binding) are due
to the strength of this H-bond between stigmatellin and reduced ISP.
The same argument goes for nHDBT, with the qualiﬁcation that the
effect onmidpoint potential is smaller (consistentwithweaker binding),
and the lack of binding to ISP-depleted bc1 has not been reported.
Additional experimental results, including the effect of MOA inhibitors
and “mobility mutants” on the Em of the ISP, can be explained by
assuming that ubiquinone binds with an H-bond to the ISP like
stigmatellin and UHDBT, and binds more tightly when the ISP is re-
duced, raising its Em [44,45]. Note that this is the condition (oxidized
quinone and reduced ISP) giving rise to the epr gx = 1.80 signal,
sharpened and shifted to higher g values from the soluble ISP signal.
The midpoint potential of the ISP in quinone-replete membranes is
higher than that of the soluble fragment. MOA inhibitors such as3 The authors qualify this by observing that it is difﬁcult to be certain that the
ferricyanide-treated sample was not reduced by radiation during data collection.myxothiazol lower the Em of the ISP, although crystal structures
show no contact. This could be due to their displacement of endoge-
nous quinone, if quinone raises the Em.
A series ofmutations in the neck region of the ISP or the ef loop of cyt b
results in “mobility defects” of the ISP in bacteria [46–50] and yeast [51].
These mutations affect the midpoint potential of the ISP in a way that
parallels their effect on the equilibrium. Since the mutations are in cyt b
or a part of the ISP distant from the cluster, they would not affect the
intrinsic Emmeasured in the isolated ISP fragment. Furthermore the effect
on Em is nearly abolished in the presence of myxothiazol [47]. The most
likely explanation [44,45] is that endogenous quinone binds more tightly
to the reduced form in the b position, and that the oxidized form, lacking
this stabilization, is predominantly in the c1 position. Since tighter binding
to the reduced formonly occurs in the b position (where the ISP can inter-
act with the quinone), the equilibria for movement between b and c1
positions must be considered in calculating the effective Em of the ISP.
For the mutation-induced changes to modulate the effective Em of the
ISP as observed, it has to be assumed that the oxidized ISP is predomi-
nantly in the c1 position. Put another way, this means that ubiquinone
induces the b position, but only if the ISP is reduced. This is consistent
with observed redox effects on the ISP position monitored by EPR in
oriented membranes [52].
Again, since the protein surface of the ISP is not affected by its redox
state, the dominant force which speciﬁcally holds the reduced form in
the b position must be the H-bond to the redox-sensitive cluster-
ligand histidine. The mutation most favoring the b position (6Pro)
raised the midpoint potential to 460 mV [48] compared to a value
around 290 mV for the soluble fragment, implying that the reduced
form is stabilized by 3.9 kcal/mol relative to the oxidized form. Since
the ISP Em in the wild-type bc1 complex is only about 25 mV more
positive than that of the soluble fragment, all but ~0.9 kcal/mol of this
is cancelled out by the unfavorable equilibrium for attaining the b posi-
tion in order to make the bond, in the wild-type complex. The most
likely sink for this energy is the requirement to melt one turn of helix
in the neck of the ISP in order to reach the b position [44,53–55]. The
longer neck of the alanine insertion mutants and the low helical pro-
pensity of the proline or glycinemutantsminimize that energy require-
ment. Thus thewild-type ISP is “spring-loaded” to facilitate dissociation
of the product complex [44]. Although the equilibrium for the reduced
ISP is toward the b position, it can be surmised from the rate of
re-reduction of ruthenium-ﬂash-oxidized cyt c1 that reduced ISP is leav-
ing the Q site at a rate near 16,000 s−1 in the wild-type complex [56], if
it is assumed that most of the reduced ISP in this experiment is docked
at QP, bound to oxidized quinone before the ﬂash. This is considerably
faster than the steady state turnover of the complex or the ﬂash-
induced reaction-center driven QP-site reaction, and so is not a rate-
limiting step. In a proline neck mutant, this rate became very slow
(25 s−1) with an increased activation energy, and became the rate-
limiting step. According to the “spring-loaded” description of the
mechanism, this would be because the spring was drastically weak-
ened by replacing two high-helical-propensity alanine residues
with helix-breaker proline, and the increased activation energy cor-
responds to the energy to dissociate the product complex with less
aid from the spring.
Presumably the oxidized ISP binds tightly to the QP site with
quinol present to form the reactant complex, but this is hard to access
experimentally due to the instability of that redox combination
(oxidized ISP and reduced ubiquinone). However from the offset in
rate of the bifurcated reaction as a function of Eh from the midpoint
potential of ubiquinone in the membrane, or from the offset of pH
dependence curve from the pKa known for the soluble Rieske frag-
ment, it has been estimated that the oxidized ISP binds ubiquinol 14
times more tightly [57]. Such preferential strong binding of reaction
partners in the “allowed” forward and reverse reactions may contrib-
ute to a double-gating mechanism to prevent bypass reactions [58].
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tion mutants that increase the midpoint potential, some mutations in
the ef loop and “box 1” of the ISP lower the midpoint potential. The
effect is additive with that of the neck mutants: L286F lowers the Em
by 50–60 mV in wild type or in insertion mutants with Em's elevated
by 60 or 100 mV [48].We attribute this to stabilization of the c1 position
by the mutation. In the c1 position, which will be described in the next
section, there is a thin line of contact between the ﬁrst cluster-bearing
loop (which includes Box I) of the ISP and the most distal portion
of the ef loop of cyt b, with probably two H-bonds and several
van-der-Waals contacts. Any mutation that stabilizes this contact
could shift the equilibrium toward the c1 position. Mutations of this
type arise as revertants to the neck mutations that stabilize the b
position, suggesting the need to keep this equilibrium within a certain
range. And the mobility mutants in the ef loop reduce or prevent the
interaction of the ISP with quinone as observed by EPR spectroscopy,
consistent with shifting the equilibrium so that even the reduced ISP
spends most of its time in the c1 position.
In this we are assuming that the mobility mutations affect the
equilibrium between the b and c positions, which is only a hypothe-
sis. However it seems to be the simplest way to explain the various
observations with these mutations, especially the compensatory
effects of neck and ef-loop mutations and the fact that the 6-Gly
and 6-Pro substitutions had essentially the same effect. These two
mutations were designed to have the opposite effect on neck “ﬂexibil-
ity”. The ﬁnding that increased rigidity and increased ﬂexibility had
similar effects, and both could be partially overcome by a decrease
in neck length, is hard to explain any other way. In fact no special
ﬂexibility is required of the hinge — the ﬂexion is spread out over
four residues, and does not require any ϕ − ψ angles prohibited for
general residues. One thing Gly and Pro have in common is low
helical propensity, which would reduce the energetic cost of melting
the helix to allow approach to the b position. And the additive effects
of neck and ef-loop mutations on the ISP Em is nicely explained by
assuming they both affect the equilibrium between b and c1 positions.
The H-bond with Q cannot be the whole story, though, because
1) the neck insertion mutants still raise the midpoint potential slight-
ly in the presence of myxothiazol [47], or with the Q-pool extracted
[59], and some ef-loop mutants (RcT288S) [49] lower the potential
even below that seen in wild-type with myxothiazol. This suggests
that the b position still stabilizes the reduced form of the ISP more
than the oxidized when the QP-occupant cannot H-bond the ISP.
Perhaps some residue of the protein, such as Y279 (302), can form a
much weaker redox-sensitive H-bond. Perhaps such interactions
could account for the difference between the EPR spectrum of the
soluble fragment and that in the presence of myxothiazol, especially
with the neck-relaxing mutants (Fig. 1b of [47,59]).
2.2. How do famoxadone and related inhibitors, which do not form an
H-bond with His161, ﬁx the position of the ISP?
Famoxadone [26,29] and structurally related JG144 [15] and
fenamidone [24] ﬁx the ISP at high occupancy near the b position.
Famoxadone binds very weakly to the ISP-depleted bovine bc1 complex
as judged by red-shift titration, with half-maximal effect around 30 μM
(LSH and EAB, unpublished observations). This suggests a mutual
stabilization interaction, with famoxadone stabilizing the ISP in the
famoxadone position and the ISP (in the famoxadone position) sta-
bilizing the binding of famoxadone, but without any direct physical
interaction to explain the effect.
The position is signiﬁcantly different from the ﬁxed position with
stigmatellin or UHDBT, with the Fe2S2 cluster about 1.5 Å farther from
cyt b and the extrinsic domain rotated 10° relative to the position
with stigmatellin (Fig. 1 and [24]). And although there is no H-bond
from the inhibitor to the ISP, there is an H-bond from Tyr279 of cyt
b to His161 in the presence of these inhibitors.We considered the involvement of Y279 in a previous paper [24].
Certainly the H-bond must stabilize the famoxadone position. But for
it to be triggered by famoxadone binding would require conforma-
tional coupling between the binding site and y279, in which case
the “H-bonding” and “conformational switch” hypotheses start to
merge. As discussed in that paper, famoxadone could either stabilize
the H-bond from Y279 to the ISP, or it could destabilize a competing
intra-subunit H-bond with Ile269. The binding site of famoxadone is
more like that of the MOA inhibitors than like stigmatellin, being
more proximal and involving an H-bond from a carbonyl O of the
inhibitor to the backbone N of Glu272. Interestingly, mutation of
Y279 to Asn, Gly, Ala, or Ser results in resistance to myxothiazol but
not to stigmatellin, despite the distal location of Y279 [57,60]. How-
ever mutation to Phe did not give resistance, so the H-bond must
not be important for this effect.
To test the involvement of Y279 H-bond for the famoxadone effect,
we created the mutant Y279F in Saccharomyces cerevisiae (DeBari,
unpublished). As previously reported for the equivalent mutant in
bacteria [57,60], the bc1 complexwas functional.We have not yet devel-
oped a crystallization protocol for the yeast bc1 complex, so we deter-
mined afﬁnity for famoxadone as a measure of the mutual stabilizing
interaction. The mutant IC50 was 2- to 3-fold higher than wild-type,
implying that the Y279 H-bond contributes some to the mutual stabili-
zation. This effect is small compared to the ~30-fold decrease in afﬁnity
for famoxadone seen with the ISP-depleted complex. While that work
wasunderway itwas shown thatmutationof the corresponding residue
in R. capsulatus does not lead to famoxadone resistance [60]. Thus
presumably the ISP is still held in the famoxadone position in the
absence of the H-bond to it from Y279, and this residue is not responsi-
ble for the effect of famoxadone on the position of the ISP. Itmay be that
no one residue or effect is, but rather a large number of small effects
including that of Y279.
Like the MOA inhibitors, famoxadone must exclude ubiquinone
from the site, and so we would expect the same slight depression of
the midpoint potential of the ISP if there is no preferential binding of
one redox form. The effect of famoxadone on the Em has been deter-
mined indirectly by its effect on the equilibrium between cyt c1 and
the ISP, and comparedwith the valuewithMOA inhibitors azoxystrobin
and MOA-stilbene using the same method [26]. In fact the Em with
famoxadone is about 50 mV higher than with the MOA inhibitors, im-
plying tighter binding of the reduced form. Again assuming only the
H-bonds to cluster-ligand histidines are redox-sensitive, and noting
that in the famoxadone position His161 H-bonds Y279 of cyt b, we
would be forced to conclude that this bond is strongerwith the reduced
ISP. It would be useful to test the effect of famoxadone on the Em of the
ISP with the Y279F mutant.
2.3. Why do we see “distal” or “c” position(s) in some crystals, but the
“released” or “mobile” state in others?
This is the main difference that leads to the two different para-
digms for the two crystal forms that allow movement of the ISP. In
some crystals, including the chicken orthorhombic crystals, the ISP
can be found in a deﬁned position that places the cluster near cyt c1.
This c1 position of the ISP varies depending on the crystal form. To a
large extent the differences in c1 position may be attributed to differ-
ent crystal contacts, and it might be argued that there is no true c1
position and the positions seen are due to artiﬁcial stabilization by
crystals contacts. We believe that there is one c1 position relevant
for the native enzyme, but that it is rather tenuous and subject to
being modiﬁed by crystal packing forces.
The position of the ISP found in chicken crystals with bound MOA
inhibitors is labeled in Fig. 1 as the c1 position. Hexagonal (P6522)
crystal 1be3 has the extrinsic domain rotated even farther from its b
position, which brings it close enough to cyt c1 for an H-bond
between a heme propionate and His161 [9]. Crystals of bovine or
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between (Fig. 2 of [32]).
However, in the P6522 crystal form, the main crystal contact
connecting dimers in the lattice involves an ISP extrinsic domain
of one dimer inserted in the depression between Core proteins of
another dimer (Fig. 2). Thus changes in cell parameters due to dehydra-
tion and cryocoolingwill affect the forces exerted by the crystal contact,
and may account for the different positions seen with this crystal form,
and perhaps none of the positions seen with this form represents a
particularly stable position for the ISP in the native complex in the
membrane.
The orthorhombic crystals of chicken bc1 with the ISP in the c1
position (PDBID 3L70 through 3L73) are affected by crystal contacts
to a lesser extent, if at all. There is a possible interaction between
Asp190 in the ISP of the second monomer (chain R) with Lys77 in
subunit 6 (chain S) of another dimer. Both side chains are disordered
so it is impossible to say whether they are arranged to form that salt
bridge, but the ISP of chain R has somewhat lower B-factors and
higher occupancy than that of NCS-related chain E, and that may
result from stabilization by this contact. Nonetheless the position of
chain R is essentially the same4 as that of chain E which makes no
contacts, and both move to the b position when the crystals are
soaked with stigmatellin (neither chain has a crystal contact in the
b position), suggesting that the crystal contact has little inﬂuence
on the position of chain R. Occupancy ranges from 0.85 to 0.93 for
chain E and 0.90 to 0.98 for chain R in the four structures mentioned,
so the ISP is in this position in the great majority of asymmetric units,
but with relatively high thermal displacement: average B- factors for
protein atoms in residues 73 to 196 are 146 to 164 Å2 for chain E and
104 to 124 Å2 for chain R. Due to partial occupancy in the major
position and/or high B-factor, the ISP extrinsic domain is poorly
ordered. The disordered electron density was the ﬁrst indication
of mobility of the ISP [7].
In the tetragonal crystals co-crystallized with inhibitors of the Pm
class (MOA inhibitors) the occupancy judged by Fe anomalous peak is
low, signifying the majority of the ISP is distributed over a range of po-
sitions too thinly to be seen in the electron density. This is the “released”
or “mobile” state, where of course “released” and “mobile” refer not to
the modeled position but to the majority of the ISP which is not seen
because it is dispersed.
The authors emphasize the occupancy, i.e. the amount of ISP
remaining ﬁxed, with little discussion of the exact location at which it
is ﬁxed. The ISP is modeled in all of the deposited structures for this
crystal form, and comparing the different structures from this space
group with each other and with structures from other crystal forms, it
becomes clear that while the structures with Pf inhibitors have the ISP
ﬁxed in the same b position as structures with Pf inhibitors in other
crystal forms, the low-occupancy ISP in the released state is modeled
in a signiﬁcantly different position, whichwe have called the “released”
position [24]. It might better be called an alternate, less stable, ﬁxed
position from which most of the ISP escapes to the truly released posi-
tions, so we have labeled it “low-afﬁnity ﬁxed position” in Fig. 1.
However the important thing here is not that there is an alternate,
less stable ﬁxed position near the b position, but that there is not a
stable position near the c1 position to capture the ISPwhen the b position
becomes unavailable. Below we examine the c1 position in crystals that
do exhibit it, consider what stabilizes it and whether it depends on
crystal contacts that may not be present in the tetragonal crystals.
Before going on, though, it is worth pointing out that in some cases,
the c1 position has been observed in the tetragonal crystals. In the 1998
paper [25] it was reported that co-crystallizing with MOA-stilbene
“abolished the anomalous signal for the FeS at the position observed in
the native crystals … a minor peak appeared closer to cytochrome c1”.4 Superimposing the cyt b monomers on each other superimposes the IS cluster
within 0.88 A and the ISP with an angle of 3.8°.And this “appeared consistently in all forms of MOA-stilbene containing
crystals”. This peak is depicted in the anomalous difference map, Fig. 3A
of [25]. The peak attributed to ISP cluster there appears to be precisely
where it is in the chicken c1 position (The apparent difference between
that ﬁgure and Fig. 6a of Zhang et al. [8] is due to different rotation
about the dimer axis). However the signiﬁcance of this peak was
downplayed in the discussion due to low occupancy in that position,
and when a structure with MOA-stilbene (1sqq) did come out (based
on data collected after the ﬁrst paper appeared) it had the ISP in the
low-afﬁnity ﬁxed position (near the b, not c1 position). Thus the differ-
encemaynot be absolute butmay result fromadelicate balance between
the released and c1 position, depending on pH and ionic strength of the
crystallization solution and crystal packing forces.
What stabilizes the c1 position in the chicken orthorhombic crystals?
If the ISP extrinsic domains in the chicken crystalmake no contactswith
other dimers, the c1 position must be stabilized by contacts within the
dimer, which would in principle be relevant for the native enzyme in
the membrane. When it is in the c1 position, the main contact between
the ISP extrinsic domain and the rest of the complex is between the ﬁrst
cluster-bearing loop of the ISP and the ef loop of cyt b. Beside that there
is only the neck region which tethers the ISP to the transmembrane
domain of the complex, Lys94 which may make an H-bond to cyt b,
and in some cases there is the above-mentioned H-bond with the cyt
c1 heme propionate.
Fig. 6 shows the details of the interaction of the ISP in the c1 positions
with the ef-loop, in hexagonal (P6522) crystals (Fig. 6A, from 1be3) and
the chicken orthorhombic crystals (6B, 3L71). Seen from this angle, the
ISP seems to be perching on the ef loop. As seen in the chicken structure
of Fig. 6B, the side chains of Leu263, Val264, Thr265, and Pro267 extend
horizontally on either side of the backbone, while Pro266 extends
downward, leaving a relatively ﬂat, broad upper surface for the ISP to
rest on. Likewise on the ISP Leu142 and Cys144 extend horizontally,
with Gly143 between, permitting the backbones of the two stretches
to come together. Fig. 6C identiﬁes the speciﬁc contacts involved.
There are two potential H-bonds between the two: 265N in cyt b with
142 O in the ISP, and highly conserved Thr265 in cyt bwith a backbone
N on the ISP.
As discussed in the previous section, mutations in this part of the ef
loop and the ﬁrst cluster-bearing loop of the ISP result in ISP mobility
defects that seem to affect the equilibrium between c1 and b positions.
This lends credence to the idea that this contact is involved in the c1 po-
sition of native cyt bc1 in the membrane, and not an artifact of these
crystal forms. The residue Thr265 involved in both of these contacts is
highly conserved. Mutations of this residue (288 in Rhodobacter) result
in loss of activity or decreased activity due to “mobility defect” of
the ISP.
Fig. 6C shows the same view as 6b rotated 90° so that the contacting
backbones are in the plane of the picture, to identify the contacts.
Although the ef loop looks very unsupported in this format, in fact it is
wrapped securely around Gln138 and supported by that residue and
Trp142, with many H-bonds to those residues and others at the begin-
ning of the cd1 helix.
What is different in the 1be3 structure, which has the cluster closer
to cyt c1 allowing anH-bond between the cluster ligandH161 and heme
propionate of cyt c1 [9]? Fig. 6A shows thismost extreme c1 position, for
comparison with the chicken structure in Fig. 6B. In both panels the ISP
cluster-bearing tip is facing toward us, a little to our left. In A the 1be3
structure is rotated farther to the left, bringing the cluster closer to
heme c1. The ISP overhangs the contact with ef that we have been
discussing. Note that the carbonyl O of 141 (white arrow) is well to
the right of the ef loop in panel B but a little to the left in panel A,
where it is H-bonding Thr265 (264 beef) which has rotated about its
backbone to face upward towards the ISP. Val264 becomes Asn263 in
beef. This residue projects toward cyt c1 and could potentially make
an H-bond with the forward leaning ISP loop 1 of this crystal, although
that bond is notmade in the deposited coordinates. If so this amino acid
Fig. 6. Underpinnings of the c1 position. In the c1 position, loop 1 of the ISP rests on the
top of the ef loop. These contacts presumably are responsible for ﬁxing the c1 position
in the absence of crystal contacts, as in chicken crystals (B, C; structure 3L71). In the
hexagonal beef crystals (A; stereo view; from structure 1be3), the ISP is contacted by
core proteins of another bc1 dimer, visible along the top of the ﬁg. in gray (left) and
pink (right), which may be responsible for its different positions. Cyt c1 (magenta) is
on the left with its heme propionates extended toward the ISP (orange protein; cluster
with yellow and grey sulfur and iron atoms). Cyt b is below in various shades of blue
and green. The arrow indicates ISP:141 O to dramatize the difference in relative posi-
tions of the ISP and cyt b in the two structures. Figure made with Molscript [89] and
Raster3D [90].
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cluster in 1be3 being closer to cyt c1. Finally, Leu263 (chicken sequence)
contacts Val138 on the descending branch of the ﬁrst cluster-bearing
loop; the other side of the loop from the residues discussed so far.
What does the “neck” region tell us about the position of the ISP in
the two crystal forms? As described above in connection with the
spring-loading, approximately one turn of helix in the neck region
melts when the ISP goes from the c1 position to b position. What does
it look like in the low-afﬁnity ﬁxed position seen in the released
state? The neck is nearly identical to that in the c1 position. This appears
to say that the helix melting occurs during themovement from the low
afﬁnity ﬁxed state to the b position, not during the much larger motion
from the c1 position to the low-afﬁnity position. This would imply that
the “spring-loading” only serves to pull the cluster away fromQPby 4 Å—
enough to break the strong hydrogen bond in the product complex.
Why is the c1 position not stabilized in the sameway in the tetrago-
nal crystals when the ﬁxed position is not available due to binding a Pminhibitor? There could be a crystal contact in the tetragonal crystals that
prevents the ISP from achieving the c1 position, or destabilizes the c1
position. In those crystals with the shortest c axis there is some contact
between the Lysines 103 and 104 in the helix on the top of the ISP with
the Core 2 protein of a symmetry-related molecule in the next layer. In
2fyu (famoxadone ﬁxed position) there is a strong (2.82 Å) H-bond
from the side chain of Lys103 in the top of the ISP extrinsic domain to
backbone oxygen of residue 349 in Core 2 of another monomer.
In the crystalswith Pm inhibitors (1sqb, 1sqp, and 1sqq) the rotation
of the extrinsic domain brings Lys 103 and 104 into interaction with
residues 351 and 352 in the same Core 2 protein. This contact could
be responsible for stabilizing the “low-afﬁnity ﬁxed position”. If the
occupancy in the low-afﬁnity ﬁxed state is low as inferred from anom-
alous peak height, the ISP must not be very strongly ﬁxed by this inter-
action. However if the anomalous peak is low because of high B-factor
in the undocked cluster tip, and occupancy is actually high; it could be
that this interaction is holding the protein in this conformation and
preventing it from moving to the c1 position.
To see if crystal contacts would interfere with the c1 position as
seen in the chicken crystals, one can superimpose chicken structure
3L70 (in the c1 position) with 2fyu based on cyt b. In the resulting c1
position the contact with the next layer did become closer, with
2.07 Å between Cα of residue 104 in the ISP and N of 354 in Core 2
of the symmetry-relatedmonomer. It is not clear that this would desta-
bilize the c1 position however, as the ﬂexibility of the protein might be
expected to absorb the clash and the contactmight actually stabilize the
c1 position, possibly in a slightly different position due to the contact as
in 1be3.
The difference could also be a species difference, since the c1 posi-
tion of an unfettered ISP has been seen only in the chicken crystals,
and the released state only in bovine. Since the unfettered chain E is
less than 100% occupied in the chicken c1 position, and the bovine
crystal in the released state can show signiﬁcant accumulation in
this position under some conditions (Fig. 3a of [25]), it may be that
a slight change in the energy balance due to an amino acid change
could make the difference, as could a difference in pH or ionic
strength of crystallization. Based on the procedure described [7,61]
for the tetragonal crystals, the ﬁnal ionic strength and pH before
vapor diffusion would be 0.265 M and 7.2, compared to 0.1 M and
6.8 for the chicken crystals. And the early report of a tetragonal c1
position with MOA-stilbene may have been from while the procedure
was still evolving, with slightly different conditions allowing observa-
tion of the c1 position. If one of the ef-loop mobility mutants that
depress the Em of the ISP by stabilizing the c1 position could be crys-
tallized (Rhodobacter or yeast) it would be expected to show a c1
position. On the other hand the neck mutant +2ala should allow
the complex to be crystallized without stigmatellin in the forms
requiring the b position, and might well allow visualization of the
tightly bound ubiquinone at the QP site if our ideas are correct.
2.4. What accounts for the different behavior of the ISP in the absence of
inhibitor, in the tetragonal beef crystals vs chicken crystals?
What state or position prevails in the absence of inhibitor? If we go
by position, the uninhibited chicken crystals are in the same state as
with Pm inhibitors, in the c1 position. Thus it is the Pf inhibitors that
have a big effect, moving to b position, while Pm inhibitors have no
effect on position but increase occupancy at the c1 position slightly.
Conversely, the tetragonal crystals in the absence of inhibitors have
the ISP in the same position as with pF inhibitors, the b position (but
at lowoccupancy), and Pf inhibitors increase the occupancywith almost
no movement, while Pm inhibitors cause movement ~4 Å to the
low-afﬁnity position with even lower occupancy.
This is a different question than the previous one about the position
in the presence of Pm inhibitors. However the explanation may lie in
the same fact that the chicken crystal has a stable c1 state — regardless
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tal packing forces, or a true physiological c1 state that for some reason is
not reached in the tetragonal crystals. In the absence of inhibitors the c1
position could be most stable in those crystals where it is available,
followed by the ﬁxed b position, followed by low-afﬁnity ﬁxed
position. Pf inhibitors stabilize the b position making it even much
more stable than the c1 position, so lead to b position in both. Pm
inhibitors destabilize the b position, so the chicken crystals remain in
c1 position, while tetragonal crystals move from b to low-afﬁnity ﬁxed
position.
That picture is not very consistent with the H-bond explanation and
especially the spring-loading concept, which predicts the spring loading
will make the b position very unstable unless there is a good strong
H-bond to compress the spring and hold the ISP in the b position. To
explain partial occupancy of the b position in the absence of inhibitors
with this hypothesis we have to propose that something, perhaps
endogenous ubiquinone, is bound at a minority of Qo sites and makes
the H-bond to hold the ISP in the b position. It need not be that the
tetragonal crystals have more ubiquinone than the chicken ones.
Assume that in both crystal forms less than half of the Qo sites have
ubiquinone bound. In the tetragonal crystal, those without ubiquinone
have the ISP “released” and invisible, so the crystals show the minority
bound to sites with ubiquinone. In the chicken crystals that minority
bound to sites with ubiquinone is overwhelmed by the majority in the
c1 state, so the latter gets built in the model. Adding Pm inhibitors
displaces the quinone and releases more ISP to go to the c1 position,
increasing occupancy (compare occupancy of structures 3L70, 71, 72
with native structure 3H1H: 0.93, 0.91, and 0.88 vs 0.80 for chain E,
and 0.98, 0.98, 0.95 vs 0.85 for chain R).
This may not be a very tenable explanation for several reasons. First,
there may not be enough ubiquinone in the preparations to occupy a
signiﬁcant fraction of the QP sites. It was reported that the bc1 prepara-
tion used for crystallization contained 0.74 mol Q per mol cyt c1 [7,61],
but since quinone is seen at the QN site, a good fraction of an equivalent
must be there. Second, if the crystals have been treated with oxidant
such as ferricyanide, or crystallized in its presence, this should eliminate
the ﬁxed position just as Pm inhibitors due, since we concluded above
that the oxidized ISP does not bind quinone. On the contrary, structure
1ntm which was fully oxidized before harvesting had a higher Fe2S2
cluster anomalous peak than 1ntz, in which cyt c1 was partly reduced
(Both are at the ﬁxed, or b, position)[62]. Possibly photoelectrons
from the X-rays rapidly reduced the ISP. Third, if endogenous ubiqui-
none is responsible for holding the ISP in the ﬁxed position without
inhibitors, treating with excess quinone should increase the amount
in the ﬁxed position, and perhaps allow visualization of quinone at QP
in a reliable way. This must have been tried many times but no such
result has been reported.
3. Does residue Y132 move upon binding nHDBT?
The importance of this highly conserved residue was shown by
Saribas et al. [63] who mutated the corresponding residue (Y147) in
R. capsulatus. Mutation to F, L, or V hadminor effectswhile A or S severe-
ly inhibited the complex. The mutants had normal occupancy of the QP
site by quinone and stigmatellin, and normal interaction of the ISP with
these as judged byEPR. Only the rate of oxidation of quinolwas affected.
Similar results were obtained in yeast byWenz et al. [64]. The Y132 OH
group is involved in a putative H+ exchange pathway, which could
account for the ~2-fold decrease in activity of Y132F, but apparently
this role is not necessary for activity.
Y132 does not vary signiﬁcantly in position in the X-ray structures
with various inhibitors, except for 1sqv with UHDBT [26]. In this struc-
ture Y132 (Y131 in beef) has swung around to direct its OH at the inhib-
itor, forming an H-bond with a keto group of the inhibitor (Fig. 7B). An
earlier structure of an alkyl-HDBT-inhibited yeast bc1 complex is
modeled with Y132 in the conventional place. This is 1p84, yeast bc1with heptyl-HDBT [65]. The binding is much like that of stigmatellin
except that E272 carboxylate does not H-bond the inhibitor. A water
molecule is bridging between the inhibitor and E272N, in much the
same position as the carboxylate in most structures with stigmatellin.
Does the conformation depend on species, the length of the inhibitor
tail, or perhaps on the crystallization conditions? The yeast structure
is somewhat higher resolution (2.50 vs 2.85 Å). Unfortunately data
was not deposited for either structure, which precludes independent
evaluation of the density, or modeling each as in the other and reﬁning
to allow for model bias. We have a low resolution (3.2 Å) dataset of
chicken bc1 with UHDBT bound, which we modeled as in the yeast
structure. In one of themonomers there is a blob of unaccounted densi-
ty in the position of the tyrosine ring of the bovine structure (Fig. 7B).
We believed this to be a cluster of water molecules or even just noise,
especially since density in the corresponding place in the other mono-
mer is weaker. However modeling as in 1sqv and reﬁning (Fig. 7C),
the resulting density is somewhat consistent with that model. At low
resolution, model bias is more of a problem. Based on this data we
would not propose an alternate position for Y132, but we could not
rule it out. Data on nHDBT-resistance of the Y132 mutants would be
useful.
4. What is the signiﬁcance of the cis-peptides at the beginning of
transmembrane helices C, E, and H of cytochrome b?
As of 1999, 5.7% of Xxx-Pro peptides in the PDB were in the cis con-
formation. Cyt b contains 20–30 prolines (19, 21, 25, 28, 29) for yeast,
beef, chicken, and R. sphaeroides and capsulatus). And thus it is not
very surprising that cyt b contains 2 or 3 cis peptides. However it is
interesting to note that they are highly conserved and thus likely to be
important for proper folding of cyt b, and to speculate about their role
in the folding process and the possible involvement of prolyl isomerases
in cyt bc1 assembly.
There are three locations in cyt b that generally contain cis-peptides,
with the second (i+1) residue of the peptide (usually Pro) correspond-
ing to yeast residues 109 (at the beginning of helix C), 223 (at the
beginning of helix E), and 347 (at the beginning of helix H) in S.
cerevisiae. All three of these are cis-peptides in all bacterial structures
solved to date, e.g. R. capsulatus (1zrt;), R. sphaeroides (2qJy etc.), and
P. denitriﬁcans (2yiu). The numbering is the same in all three, the
cis-peptide i+1 residues being P124, P246, and P/I388.
Vertebrates and other metazoans have a two-residue deletion in
cyt b which removes the two residues making the cis-peptide at the
beginning of helix C, and there is no cis-peptide near there in the
available vertebrate structures. The bc loop is very short, and the
deletion just makes the turn tighter in vertebrates, with the 4 residues
107RSPR of yeast cyt b being replaced by two, 109CF, in chicken.
Residue 223 is a highly conserved Pro inmost organisms butmutated
to Ser, Gly, or Asn in some Saccharomycetales; in S. cerevisiae it is Ser.
This is a cis-proline in all non-saccharomycete structures available.
Although the peptide His222-Ser223 has been modeled as trans in
yeast structures to date, examination of the electron density and differ-
ence maps calculated with the high-resolution structure 3cbx, and
further reﬁnement after changing the model, clearly show that there is
a cispeptide betweenHis222 andSer223 (Fig. 8a andE.A.B., unpublished).
An interesting mutation converting Ser223 to Pro in S. cerevisiae will be
discussed in the next section on function of the Core proteins.
A similar case is found with the residue at the beginning of helix E.
This is Pro347 in yeast, is a cis-proline in available bc1 structures, and
is conserved in mitochondrial (except some ﬁsh and sea urchins) and
most bacterial cyt b. However in a few Rhodobacteracia such as
Paracoccus and Bradyrhizobium it is Ile. In structure (2yiu) this residue
(I388) is modeled with a cis peptide, so again the cis-peptide is con-
served even when the Pro residue is not.
As for the b6f complexes, they seem to have cis-prolines at the be-
ginning of helix C and E. There is no helix H, and the superimposed
Fig. 7. Alternate conformations for Y132 and M139 in the presence of alkyl-HDBT? A. Superposition of structures 1p84 (thick bonds) and 1sqv (thin). B and C, Density maps using
unpublished 3.26A data fromchicken bc1 crystal withUHDBT. Reﬁnedmodels startingwith the conformation of 1p84or 1sqv are shown in both. In B, the density is calculatedusing phases
from themodel based on 1p84which is shownwith thick sticks. In C, themodel based on 1sqvwas used for phases and thatmodel is renderedwith thick sticks. Figuremadewith O [88].
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alignment puts P150 of subunit IV near P347 of yeast cyt b, there is no
structural reason to align them.
Superimposing the structure of yeast bc1 complex and cyt b6f from
Chlamydomonas, yeast P109 aligns with P113 of b6 and yeast S223
with P33 of subunit IV. Both were modeled with cis peptides in the
Chlamydomonas structure 1Q90. Theyweremodeled with conventional
trans peptides in the structures from cyanobacteria, however examina-
tion of the electron density for 2E74 suggests that cis peptides would ﬁt
better here5.
Why do cis-peptides occur at the beginning of helices? Pal and
Chakrabarti [66] reported non-pro cis peptides to be over-represented
at the N-termini of helices, in what Richardson and Richardson [67]
have called the N-cap position, the residue at the start of the helix
whose O receives an H-bond from the helix but N does not make one.
The cis-peptides at these three positions of cyt b are overwhelmingly
occupied by proline in the second position, but occurrence of non-pro
cis peptides at two positions is striking given the rarity of these bonds
(0.03%). Apparently whatever causes cis-peptides at N-termini of heli-
ces is powerful enough to maintain the cis-peptide even if the Pro resi-
due is mutated to something else, resulting in over-representation of
non-pro cis peptides while the greater number of cis-pro peptides at
theN-cap position does not stand out among the even greater frequency
of cis-pro at other positions (5.7% of x-Pro bonds are cis [66]).
Cis-peptides may serve as powerful helix-breakers to stop the
growth of a helix at a particular point once it is nucleated. Proline
itself being an tertiary amide is unable to donate an H-bond to the
O of a preceding residue. However proline residues are frequently
found in helices. Helix capping by cis-peptides may be important in
the folding of proteins. Fig. 8 shows on the left the electron density
for the cis peptide at Ser232 in yeast cyt b, and on the right the
H-bonding pattern around this peptide, with a canonical α-helix
superimposed for comparison (thin wires).
The residues around theN-terminal end of these three helices do not
superimpose well, but the H-bonding pattern is somewhat similar5 Difference maps calculated from the deposited structure and data have positive
peaks 5.9 and 6.5σ at the position where the carbonyl O of the ﬁrst residue of the hy-
pothetical cis peptide (A112 and B32) would be. Converting the peptide to cis and re-
ﬁning eliminates these difference densities. Further, The header of pdb ﬁle 2E74 ﬂags a
too-close contact between the carbonyl O of A112 and the Glu115 carboxylate of
1.99 Å, which is removed in the cis model.around residues 223 and 347. That at 223 is shown in Fig. 8b. The
carbonyl O of the second residue of the cis-peptide, ser223 in this
case, points forward making an α-helical H-bond with the residue
four ahead in the sequence. That of the ﬁrst residue, His222, i.e. the O
of the cis peptide, points backwards away from the helix, making it
impossible for this peptide to take part in helical H-bonding. However
the residue before that (221) points forward and may H-bond the
residue 3, 4, or 5 ahead in sequence. For several residues prior to that
there are no helical bonds.
Simply having a cis peptide does not force the carbonyl to point
backwards, nor is a cis-peptide required for it to point backwards
(in fact the deposited structure with trans peptide has the carbonyl
correctly pointing backwards). However with a trans peptide the ﬂip
which allows helical bonding would be greatly preferred energetically,
while having a cis peptide is not compatible with α-helical geometry.
The resulting ﬂipped peptide breaks the helical bonding, and although
the residue before the cis pair makes a somewhat helical bond, the
geometry of this turn of the helix is now so different that the helix
cannot grow back any farther.
The standard program for classifying secondary structure, DSSP [68]
assigns the helix start to the residue before the cis-dipeptide, 221 in this
case.With that deﬁnition, the usually proline residue is not theNcap but
N2 residue. The arrangement around the cis-peptide at 108–109 is
different, with the ﬁrst residue of the helix being the one after Pro109;
Pro109 not making a helical H-bond. i.e. instead of being a cap residue,
the cis-pro is separated from the helix by one residue. Maybe the
cis-peptides ﬁx the ends of helices at an early stage in folding, but in
the ﬁnal structure they are displaced from the Ncap position.
Since Pro is not required tomake the cis-peptide, there seems to be no
way to use mutagenesis to probe the importance of these cis-peptides.
However onemight expect that one of the assembly factors being discov-
ered for the bc1 complex will be a peptidyl isomerase, and its deletion
may lead to misfolding of cyt b.
5. What is the function of the Core proteins?
The two largest subunits of the mitochondrial bc1 complex were
originally termed “Core” proteins on the assumption that they would
form the core of the complex. As it turns out they are peripheral both
structurally (extra-membrane attachments on the matrix side) and
functionally (not present in bacterial bc1 or b6f). The Core proteins are
homologous to the β- and α-subunits of matrix processing peptidase
Fig. 8. The cis-peptide H222-S223 at the beginning of Helix E of cytochrome b in the yeast bc1 complex. Left, atomic model with electron density, from structure 3cx5 after further
reﬁnement. The electron density is a 2mFo-DFc map from Phenix contoured at 1.5 σ. On the right is the same model with the side chains of the helix truncated to Cβ for clarity. The
arrow indicates the carbonyl O of His222 which due to the cis-peptide points away from the helix. At the top Arg447 of the Core 1 protein is visible H-bonding this atom, perhaps
stabilizing the cis-peptide. For reference a canonical α-helix is superimposed (thin lines). In fungi other than Saccharomycetae and in most other eukaryotes and bacteria, the res-
idue corresponding to Ser223 is a proline, and mutation to proline in yeast restores function to a complex with the gene for the core 2 protein deleted. Figure made with O [88].
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imported proteins. In plants, the Core proteins are the MPP enzyme. In
vertebrates and in yeast there are separate genes coding for Core
proteins and MPP. Like MPP, the Core proteins consist of an α-β
heterodimer of structurally related bowl-shaped subunits which come
together to enclose an internal cavity, open to the outside through
one gap, or “mouth”, between the edges. The active site ofMPP iswithin
the internal cavity.
By sequence homology Core protein 1 corresponds to the cata-
lytic β subunit of MPP, and Core protein 2 to the α subunit. The
zinc binding motif of β-MPP is not conserved in vertebrate or
yeast Core 1 (Fig. 9), and the X-ray structure of a bc1 complex crys-
tal soaked with zinc did not show any Zn binding in the Core pro-
teins [69], suggesting it no longer has a proteolytic function.
However there is circumstantial evidence for a proteolytic function
in vertebrate mitochondria, in what appears to be an extreme caseFig. 9. Alignment of Core and MPP proteins around Zn-binding site. The reverse Zinc motif “H
present here only in S. cerevisiae β-MPP and N. crassa Core 1; however the beef core 1, in wh
mutation of that to S inactivates. Figure made with Clustalw at NPS@, PBIL [91].of product inhibition. MPP binds substrate peptides inside the
cavity, with the scissile bond at the active site. In vertebrate bc1
complexes, the signal peptide of the ISP is retained in the mature
complex after cleavage, and is located within the cavity of the
Core proteins. This suggests that the Core proteins may serve as
processing peptidase for the bc1 complex subunits, or at least for
the ISP. In fact if the signal peptide is cleaved by soluble MPP, it
is hard to imagine how or why it would subsequently be trans-
ferred to the interior of the Core proteins.
Furthermore the N-terminus of the mature ISP is on the outside of
the Core proteins, near the edge of the mouth (Fig. 10). This suggests
[9] that the Core proteins serve to cleave the signal peptide from the
ISP after it is inserted into the complex, and what we observe in the
crystal structure is the aftermath of the last, or only, proteolytic
event of the Core proteins. We will examine the structure to see
how consistent it is with this picture below.xxEH… E” is underlined, and conserved residues of it are in bold. The complete motif is
ich the ﬁrst H has been mutated to Y, has been shown to have proteolytic activity, and
Fig. 10. N-terminus of the Rieske ISP in relation to the putative proteolytic site of core 1. The ISP is a cyan Cα trace. Peptides to be cut by MPP bind as an additional strand on the
inside edge of sheet 1 of core 1, depicted in magenta. The rest of core 1 is yellow, core 2 is green. The bent brown helix is Helix D of core 1 which forms the lip of the mouth. A
pathway from the N-terminus of the ISP to the proteolytic binding site is indicated by cyan arrows, and it is estimated that the ISP would reach there if the sigmoid loop straightened
out. Residues 8PDF of the conserved motif are depicted on the ISP. P8 and F10 insert in the groove between side chains of β strands contributed by subunit 7 (green tube) and cyt c1
(red tube). Figure made with O [88]. Stereo pairs (cross-eyed and wall-eyed) of this view are available in the supplemental materials.
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the bovine bc1 complex after detergent treatment [70], or from het-
erologously expressed Core proteins [71]. In the latter case no
detergent treatment is required, but if the substrate is the ISP
presequence then the activity is inhibited after a single turnover
and can be reactivated by detergent treatment. This supports the
conclusion that the requirement for detergent is to dissociate the
product peptide.
Weiss and coworkers [72] used detergent and high salt to split the
Neurospora crassa bc1 complex into Core proteins, ISP, and a complex
devoid of both. Activity could be reconstituted by adding both ISP
and Core proteins, but not by ISP alone [73]. This would seem to
imply a function beyond signal peptide processing, perhaps in
re-insertion of the ISP (as described below, the mature N-terminus is
associated with the Core proteins), or in maintaining the integrity of
the structure to allow electron transport. Removal and reconstitution
of the Core proteins apparently have not been reported in any other
organism.
Another clue to the function of the Core proteins may be found in a
yeast mutation that “obviates the need for Core protein 2” [74]. This
mutation, S223P in cyt b, was originally isolated as a second-site
revertant to a mutation resulting in truncation of Core 2, and it was
shown that the cyt b mutant was still respiratory-competent with
the Core 2 gene deleted entirely. Several factors make this mutation
interesting: For one thing, there is a highly conserved proline at this
position in the wild type of vertebrates, purple bacteria, and cyt b6f
subunit IV. Thus the mutation is restoring the residue that practically
every other bc1 complex has in the wild type. Secondly the peptide
bond between P223 and the preceding residue is cis in the available
structures: chicken, cow, R. capsulatus or sphaeroides, and b6f. Thiscould explain the highly conserved proline, as non-proline cis pep-
tides are rather unstable. As described in the previous section, this
is one of three cis peptides occurring at the start of transmembrane
helices in cyt b, and they may play a role in folding; in deﬁning the
start of the helix, and although the Pro residue is not conserved in
wild-type yeast, the peptide is still in a cis conformation.
But what has this got to do with the function of the Core 2 protein?
This is not entirely clear, as Core 2 does not even make van-der-Waals
contact with cyt b. However residue Arg447 in Core 1 protein makes a
double H-bond to the carbonyl of residue 222, stabilizing the cis confor-
mation of the 222–223 peptide. A highly speculative scenario is the
following: If the cis-peptide is required for maintaining the proper
fold of cyt b, perhaps the proline is stable in the cis form but serine
will revert to trans if not stabilized by the H-bond between Arg447
and the carbonyl. Arg447 is in Core 1 not Core 2, but assuming the
Core proteins form α-β heterodimers like MPP before binding the bc1,
then eliminating or truncating Core 2 would prevent heterodimer
formation and Core I alone would probably not assemble into the com-
plex. However this would not explain the need for Core proteins in
other organisms, which have proline here in the wild type. And the
H-bond with Arg447 is not special to yeast. This residue is highly
conserved in Core 1 proteins, and makes the same H-bond in beef and
chicken crystals.
The bc1 complex was not isolated from the S223P mutant to see
whether it contained any Core protein, for example a Core 1 homodimer,
or a heterodimer with MPP providing a Core 2 replacement or the entire
heterodimer. Perhaps the mutation S223P allows some such dimer to
replace the Core proteins' function. Further investigation of this mutant,
including attempts to isolate functional bc1 from the Core 2 deletion and
determine its subunit composition, would seem to be warranted.
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N-terminal region and the cleaved presequence with respect to the
Core proteins in the mature complex is indicative of cleavage of the
two apart as the last catalytic act of the Core proteins. First, does
processing of the ISP occur before or after incorporation into the com-
plex? The observation that the presequence is retained in the complex
suggested that processing occurred after incorporation [75], but this is
less compelling now that we know it is trapped inside the cavity of
the Core proteins, at least if we accept they are the protease responsible
for its cleavage. In yeast, a strong casewasmade that the second step of
processing, by MIP, occurred after incorporation [76], but what about
the MPP step, which is the only step in vertebrates?
Maturation of the ISP cluster in yeast requires subunit QCR9, and
bc1 isolated from QCR9 deletion strains by the lauryl maltoside meth-
od or digitonin extraction and BN PAGE do not contain the ISP [39,77],
however the ISP is processed to maturity in the absence of QCR9 [77].
This would seem to imply that processing occurs, or at least can occur,
before incorporation. However there is some evidence for incorpora-
tion in the absence of QCR9, in a detergent-labile, EPR-silent form
[77].
If the Core proteins function like MPP, the pre-cleavage location of
the scissile peptide in the active site can be accurately determined by
superimposing yeast MPP X-ray structures [78] on the bovine Core pro-
teins. Despite the amino acid differences, the backbones superimpose
verywell in the region of the active site. In the structure of the substrate
complex of yeast MPP with Cox4 presequence (1HR8), the backbone N
atomof the residue following the cleaved bondH-bonds to the carbonyl
O of residue 101 of the catalytic β subunit, and the carbonyl O of the
next to last residue before the cleaved bond binds to 103. This holds
the peptide so the carbonyl O of the cleaved peptide bond is directed
toward the Zn ion. Superimposing MPP on the bovine Core proteins,
residues 101 and 103 correspond to A88 and A90 in Core 1. To recon-
struct a pre-cleavage structure for the bovine ISP+Su9 precursor, we
need to move residue 1 of the mature ISP to bond with residue 88,
and next-to-last residue R77 of subunit 9 to bond with 90, of Core 1. If
this can be done with relatively small movement of the termini of
these proteins, leaving the ISP transmembrane helix in place and keep-
ing the strand of subunit 9 attached to the scaffolding site in sheet 1 of
Core 2, it supports the hypothesis that the existing condition arose by
these termini relaxing to their current position after cleavage of the
bond.
Chain-tracing of subunit 9, the leader peptide, is uncertain so the
conclusion depends on which model you use. The possibilities will be
considered in the next section. As for the mature ISP, the N-terminus
is not very close to A88, however the ﬁrst 24 residues, before the
start of the transmembrane helix, are rather unstructured and trace a
sigmoid path (Fig. 10), and it is not unreasonable to suppose they
have drifted into this position after being released by cleavage.
The transmembrane helix of the ISP starts at residue 25 of the ma-
ture protein. Before there, going from the start of the transmembrane
helix backwards toward the N-terminus, the ISP continues downward
(in the orientation of Fig. 10) along the surface of Core 1, turns back
upward and then downward again, with the N-terminus reaching near-
ly to Core 1 helix D which forms an edge of the mouth opening into the
internal cavity. Assuming everything before the transmembrane helix
may have moved after release by cleavage, we can ask if 24 residues
could stretch from the active site at residue A88 in the Core 1 protein,
out through the mouth, around helix D to the beginning of the TM
helix at 25. The path from the current position of the N-terminus to
the active site is indicated by blue arrows in Fig. 10. In themost extend-
ed β form, a polypeptide can reach about 3.3 Å per residue, so the 24
residues could reach at most 79 Å.
Residue 25 of the ISP is close to Core 1, but it is on the outside of this
bowl-shaped subunit. Assuming the peptide would have to enter the
central cavity through the mouth rather than penetrating the wall of
the bowl, it must go around Helix D of Core 1. Taking a path by residueA139 in helix D as the shortest distance, the sum of the distances from
ISP:25 to A139 and from A139 to the active site at A88, plus another
15 Å to go around A139 with a 5 Å radius gives 72 Å. Thus it would be
feasible to reach, but with little slack to spare. Of course in the
pre-protein there would be an additional 78 residues to diffuse into
the cavity, binding initially near the pre-protein N-terminus, and then
by attaching successive segments to the binding scaffold, draw the
protein in up to the cleavage site. It is tempting to propose that this
process of the Core protein drawing the presequence in until the scissile
bond is at the active site, plays a role in positioning the ISP within the
complex. However it must be remembered that mature ISP can be
used to reconstitute the bc1 complex, as has been shown in many labs
by many different procedures [72,79–83], so the presequence is not
required for positioning. In these experiments the ISP does in fact go
back in the correct position rather than adsorbing its TMH to the surface
in a position that allows function, since reconstitution is inhibited by
excess of the TMH segment [82].
What about the yeast ISP? The ISP of S. cerevisiae has a 30-residue
leader peptide which is removed in two steps — the ﬁrst 22 residues
(underlined in Fig. 11) by MPP or Core protein, and the ﬁnal octapep-
tide (double-underlined) by MIP [84]. This leaves the N-terminus of
the mature ISP shorter than that of the bovine protein by 10 residues,
measured from superimposing residues in the TMH. The difference in
length is made up in the sigmoid loop (9 residue deletion in Fig. 11),
and the N-terminus of the mature ISP is in nearly the same position as
that of the vertebrate protein, near the mouth of the Core protein
heterodimer. The backbones of the two proteins are nearly identical
for residues 7–14 of the vertebrate ISP and 6–13 of the yeast protein
(36–43 of the pre-protein), where the protein passes over β-sheet 2
of Core 1. Using this structural alignment to guide sequence align-
ment (Fig. 11) shows a motif (R/K)xP(D/N)FxxY (boxed region in
Fig. 11) in this accurately superimposing region, and the highly
conserved P and F are facing the groove in β-sheet 2 between strands
contributed by cyt c1 and subunit 7 (QCR8). Presumably this is a tight,
speciﬁc binding interaction which serves as an anchor to ﬁx the posi-
tion of the N-terminal segment. Between this and the transmembrane
helix is the sigmoid loop, which is shorter by 9 residues in yeast
(5 residues 46 to 50 replace 14 residues 17 to 30, using the pre-
protein sequence for yeast and the mature sequence for vertebrates).
From there on the sequence numbers have a constant offset of 20, lead-
ing to the confusing situation that cluster-binding histidine 161 of yeast
corresponds to cluster-binding histidine 141 of vertebrates.
What does this imply for the possibility of the yeast protein being
processed by the Cores after insertion to its ﬁnal place? Although the
mature N-terminus is 10 residues shorter, the Core proteins would be
cutting at the MPP site which is distal to the octapeptide, so only two
residues shorter than the vertebrate cutting site. And this could be
made up by the fact that the yeast protein doesn't join the vertebrate
for the ﬁrst, kinked turn of the transmembrane helix at residue 25,
but rather at 30 where the main helix begins. So it would be possible
for the scissile bond to reach the active site in the Core proteins, and
the length of polypeptide from there to the transmembrane helix
would be about the same as in vertebrates, despite the facts that the
conserved anchor segment is displaced nine residues relative to that
of vertebrates and that the MIP removes an additional eight residues
afterwards.
Although the cleaved presequence of vertebrates remains ﬁrmly
bound in the interior of the Core proteins, the shorter presequence of
yeast apparently does not, and in both the N-termini of the mature
ISPs do not. As described in the next section, the tight binding of the ver-
tebrate presequence is not at the cutting site but at the homologous site
in Core 2, one of the “scaffolding” binding sites. It involves adding a β−
strand to the inner edge of sheet 1 of Core 2. Again looking at the reac-
tant complex of the yeast MPP with Cox4, the stretch containing the
scissile bond binds in the same way on Core 1 but with a less extensive
sheet involving only three H-bonds. After cleavage the two ends would
Fig. 11. Sequence alignment of N-terminal region of Rieske ISP precursor proteins. Underlined regions indicate signal peptide sequence removed by MPP. Doubly underlined octa-
peptide of S. cerevisiae is the region removed by MIP in a second processing step. Higlighted SxR sequence A includes the R at -2 to the MPP cleaveage. Boxed region B has the
KxPDFxxY motif which in vertebrates and yeast, lies on the groove betweeen strands contributed by cyt c1 and subunit 7 (QCR8) to β-sheet 2 of core protein 1. Twin basic residues
C anchor the start of the transmembrane helix at the membrane interface. Highly conserved region D at the far right is the “neck” region including the helix which partially unwinds
when the ISP is in the b position. Figure made with Clustalw at NPS@, PBIL [91].
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The Cox4 presequence has only 17 residues and does not interact with
the binding site in Core 2 the way the vertebrate ISP presequence
does. The segment cleaved by MPP from the yeast ISP is only slightly
longer, at 22 residues, and may also not make this interaction, account-
ing for its easy release after cleavage.
Why should the presequence be retained? If the Core proteins are
involved in recruiting the ISP to the complex, then the idea [76] that
having the presequence bound would prevent those complexes that
already have ISP from recruiting another, makes sense. Or perhaps it
is just optimizing substrate binding afﬁnity. Normal enzymes must
balance substrate afﬁnity with the need to dissociate product. Unless
the ISP turns over faster than the rest of the complex and needs to be
replaced periodically, there is no need for the processing peptidase to
catalyze another cleavage, so no limit to how tightly the presequence
could be bound.
Of course this is all speculation and does not answer the question
of whether the Core proteins function as processing proteases. We
think that the idea is plausible enough to stimulate someone to ﬁnd
a deﬁnitive answer. In the case of yeast this could be as simple as
looking for Core 1 mutants that do not process the ISP, starting by
mutating what is left of the Zn-binding site. In the case of the bovine
Core 2 it was shown that mutating the Tyr71 to Thr completely abol-
ishes processing activity. Perhaps the same thing could be done with
mammalian cells in tissue culture, transfecting with mutant Core pro-
teins and knocking down the endogenous protein. It has been shown
in yeast that processing by MIP to remove the octapeptide is not
required for function [85]. If the Core proteins are responsible for
the MPP cleavage, a Core mutant might assemble a functional bc1
complex with the unprocessed N-terminus of the ISP bound to the
active site inside the Core proteins.6 Secondary structure elements of the core proteins are deﬁned in ref [7].6. What is the correct tracing for subunit 9 in the vertebrate bc1
complex, and why is it retained in the mature bc1 complex?
Why is the leader sequence of the ISP retained in themature complex,
and what is the correct tracing in the structures?
As described in the previous section, the vertebrates Rieske ISP are
synthesized with a rather long (78 residues in beef) signal peptide
which directs its import into the mitochondria. The signal peptide is
cleaved off at some point during import and assembly, but surprisingly
it is found in themature complex as subunit 9. There are several strands
of polypeptidewithin the internal cavity of the Core proteinswhich pre-
sumably belong to subunit 9 since all the other subunits have been
accounted for, but they are not well ordered except for a short stretch,
and the amino acids are not distinctive enough to allow positive identi-
ﬁcation from low resolution structures. Since the leader sequence is ap-
parently not retained in fungi, plants, or protozoans; and of course doesnot exist in prokaryotes; it presumably does not play any important role
in the basic functions of electron transport and proton pumping.
However the structure of subunit 9 may hold a key to the function
of the Core proteins. Presence of the leader sequence of the ISP inside
the Core proteins suggests the possibility that leader sequence is
cleaved by the Core proteins and never dissociates afterwards [9].
We would like to know how consistent the arrangement of the leader
sequence in the mature complex is with that scenario.
The various structures coming out in 1997–1998 all included bits
of subunit 9 in the cavity of the Core proteins, but they were quite dif-
ferent. The models have been modiﬁed some in later structures, but a
consensus has not been reached. Fig. 12A illustrates the models of the
ISP in structures 1be3 [9], 1ppj [10], and 2fyu [15]. Fig. 12b shows
schematics of the path through the density, which is apparently sim-
ilar in all the structures, and details of the ways in which the chain has
been traced. One of the challenges is that the density seems to come
together at a number of nodes where three strands of density con-
verge. This could be due to multiple arrangements in different unit
cells being superimposed in the electron density, but it could also
be due to confusion of main chain vs side chain and close connection
of the side chain to other density.
There is one stretch of 5 residues (labeled a in Fig. 12) which is well
ordered due to binding as an additional strand to β-sheet 1 of Core pro-
tein 2. This is one of the four internal sheet edges that have been iden-
tiﬁed as a “binding scaffold” for substrate peptides [78]. There is density
that can be modeled as a second strand (b) parallel to that. Then there
are stretches of density leading from near either end of the β sheet,
across the cavity, to the mouth. One of these, labeled c, runs along
sheet 2 of Core 2 near the internal edge, but not as an additional strand
of the sheet. At the end of c near the mouth, there is a helix or zigzag.
The other (d) is not modeled in 1be3 but is present in other structures
frombeef and chicken. Finally there is a short stretch (e) near the begin-
ning of strand a that has been modeled as the N-terminus in 2fyu.
The well-ordered stretch a is at least traced in the same direction
in all the models, antiparallel, as is the rest of the sheet, bonding to
residues 100 to 96 in strand D6 of sheet 1 of the Core 2 protein.
These 5 residues were modeled as 67SVSLN in 1be3, 66ASVSL in
1ppj, and 13PVLSA in 2fyu.
From the density in 1ppj and related crystals, the ﬁrst four of these
residues and the preceding one all have small side chains, so the Leu
residues in the 1be3 and 2fyu models cannot be well accommodated.
In particular L70 of 1be3 is on a residue (position 4 of the 5) which
appears to be glycine in the density of 1ppj. In 1ppj the sequence is
as in 1be3 but translated ahead by 1. This puts the big leucine 70 in
density, but V68 and S69 appear too big for their density.
In fact there are only two stretches in the bovine leader peptide
that have 5 consecutive small residues: 21GVAGA and 65VASVS. If
Fig. 12. Comparing subunit 9 as modeled in different structures. Above. superposition of
subunit 9 from bovine structures 1be3 (blue), 1ppj (green), and 2fyu (brown). Below, sche-
matic diagrams showing how those structures as well as 3L70 (chicken) and two
unpublished schemes mentioned in the text, trace subunit 9. The yellow arrow represents
strand D of subunit 2, on which subunit 9 adds an additional sheet. Upper ﬁgure made
with O [88].
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would probably be recognizable. In any case, we have not found any
stretch of sequence that ﬁts this well. It is possible that binding is pro-
miscuous with respect to register, in which case a single large residue
could be present at low occupancy at several places and not visible
at any.
In structures 1be3 and 1ppj, strand a is preceded by the stretch we
have labeled c. The connection is different, with the main chain of
1be3 passing through density which is modeled as Arg62 side chain
in 1ppj before entering strand a. On the other hand 2fyu connects
appendix e to the beginning of a, and takes the end of e as the
N-terminus. Stretch e is not modeled in any other published crystal
forms. This area is quite noisy in our chicken or beef crystals. Howev-
er on superimposing 2fyu we found that the “noise” ﬁts the ﬁrst four
residues MLSV extremely well, including the acetyl group on the
N-terminal methionine; and the next several residues reasonably
well. And this can be traced on into strand a as in 2fyu, with fair den-
sity for P10, although it puts F11, P13 and L15 in residues that seem to
have smaller side chains.
After the well-ordered β strand a, most models have the peptide
turning back on itself to make a second β strand in the sheet, but this
is not as well ordered. In the model of 1be3 this leads to the
C-terminus, but density for the last two residues (Arg Tyr) is not
good in 1ppj, and could be modeled as well by further extension of
the peptide chain into a node where other density connects. In the
tetragonal beef crystal 2fyu, the end of b connects to c. Alternatively,
it can be reasonably be modeled (in 1ppj) as connecting to the start
of segment a at one of two places indicated in scheme 5 or 6 of
Fig. 12B.
Stretch c has been modeled in opposite directions, going toward
the β strand in 1be3 and 1ppj, and away from it in 2fyu. Stretch c
has a 2-turn helix in 2fyu, or one turn of helix and a zigzag in 1ppj,
on the end near the mouth. Using the aRP/WARP autobuilding pro-
gram [86] as a bias remover (iterative reﬁnement as free atoms,
adding new atoms, and chain-building from the atoms) stretches c,
a, and b were preserved in the order of 1ppj in most cases, however
on one occasion c was reversed. Now with a further reﬁned version
of 1ppj, and omitting all of subunit 9 from both monomers to
completely avoid bias, aRP/WARP builds only three residues of c, in
the helical turn. These are going in the direction of 1be3 and 1ppj,
opposite 2fyu. With the model of 1be3 there are numerous long
side-chains in this region, and the ﬁt is pretty good but there are
enough poor ﬁts to raise some doubts. There is good density for
Cys51 with its heavy sulfur atom. Seeing the anomalous signal of
sulfur would be a good way to conﬁrm this model, but our collection
wavelength is too short and our accuracy too low to reliably locate
the sulfur atoms in Bijvoet difference maps from any of our data.
Density at the beginning of b is also not good, auto-tracing
starting with phases from a model with subunit 9 chains removed
only built a tripeptide in the middle of b with no connection at
the beginning as is made in all three structures. By making a
main-chain/side-chain switch at the junction of a, b, and d; stretch
a can be built continuing into d with a good ﬁt to the density, as in
schemes 5 and 6. In fact this is what aRP/WARP builds in the recent
experiment mentioned above. It is also building a tripeptide in b,
well positioned as another strand of the β sheet. However it has
nowhere to go since it leads into c, a, and e. Stretches c and e are
both coming toward it, unless in fact c is reversed as in 2fyu. It
could turn into a as in scheme 6. Scheme 6 is meant to imply the
N-terminus has two conformations — one in appendix e and the
other folded over into second β strand b, both feeding into a. Howev-
er a goodmodel can bemade with c leading into a as in 1be3, and this
is what aRP/WARP is building with the current starting phases. So we
have possibility of b, c, or e running into the well-ordered strand a.
They could all do, as alternate conformations, but that would mean
the occupancy of each is low.How do these models ﬁt with the idea that subunit 9 is left where
it was bound when it was cleaved from the N-terminus of the ISP?
None of the models have it binding to sheet 1 of Core 1 where the
scissile bond-containing segment binds, but as explained in the previ-
ous section that binding is not extensive and would be expected to
dissociate upon cleavage. What is most likely to be left over from
pre-cleavage substrate binding is segment a on sheet 1 of Core 2,
Fig. 13. Determining heme orientation from an omit map. Structure 1ppj after further
reﬁnement was used to look for asymmetry in the bL heme which would imply speciﬁc
orientation. The Cβ atoms were removed from both vinyl groups. After further reﬁne-
ment to convergence, maps (2Fo − Fc and Fo − Fc) were calculated. The 2Fo − Fc
map contoured at 0.3 e-/Å3 is shown in blue, and the difference map contoured at
0.27 e−/Å3 is green. The truncated heme used for reﬁnement and phasing is shown
as thick bonds. while the original reﬁned heme is shown with thin bonds to show
where the atoms were removed. Points of positive difference density show that some-
thing is missing where the Cβ atoms were removed, suggesting that the original orien-
tation was correct. The large positive difference density symmetrically located about
the heme iron probably results from aniosotropic motion of this electron-dense
atom. Figure made with O [88].
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the one bonded to residue 96 of Core 2, is 71 in 1be3 and 17 in 2fyu.
From Cα of this residue, there is a straight path of 32 Å across the in-
ternal cavity to residue 90 in Core 1 where the residue 77, that is−2
from the scissile bond, would bind (see previous section). This is too
short to be reached with the models of 1be3 or 1ppj without some
unzipping of segment a from sheet 1 but compatible with 2fyu in
which the N-terminus binds to sheet 1 of core 2.
7. Are the cyt bL hemes promiscuously oriented? And what is the
chirality of Met Sδ that ligates heme c1?
Heme b, or iron protoporphyrin IX, is a pseudosymmetric mole-
cule, with everything symmetric about a dividing line (mirror
plane) between the A and B rings on one side and C and D rings on
the other, except that the methyl and vinyl substituents on rings B
and C are switched. Since this depends on the absence or presence
of a single carbon atom at the four places, the orientation is not
always clear in low resolution structures.
All of the yeast and chicken structures, and the orthorhombic beef
structures like 1ppj, have the hemes oriented consistently, although
this may be because each structure was solved using the best avail-
able previous structure. Structures from the tetragonal beef crystals
have heme bH oriented as in the yeast and chicken structures, but
different structures have different orientations for bL. Interestingly,
the ﬁrst Cα-only structure 1qcr and the highest-resolution most
recent structure 2fyu both have heme bL oriented in the opposite
direction to the yeast and chicken structures.
Looking at our highest resolution bovine structure 1ppj, the densi-
ty seems to support our structure pretty well, but this is in part due to
model bias. As a more rigorous test, the Cβ atoms were removed from
the vinyl groups leaving effectively methyls in all four places, and this
structure was reﬁned to convergence. A difference map calculated
using phases from this model showed positive density peaks of
about 0.3 e−/Å3 at the original vinyl positions (Fig. 13). The highest
difference density around the other two substituents was below
0.1 e−/Å3, which is around the noise level of the map. A similar situ-
ation was observed in the other monomer.
This supports the idea that heme bL has a preferred orientation, spe-
ciﬁcally when viewed from His84 (83 beef, 82 yeast; from helix B side)
the rings A B, C, D or I, II, III, IV go around in a clockwise direction, as in
chicken and yeast structures, and bovine structure 1ppj. However it is
much less clear in a number of other structures. It might be useful to
compare the two orientations by calculating binding energy with a
docking program, to see if one orientation gives better contacts.
Another question regards the chirality of the S atom of the methio-
nine residue that coordinates heme c1. The sulfur atom has tetrahedral
geometry (sp3 hybridization) and two lone pairs of electrons. When
one of these lone pairs coordinates the iron, it generates a chiral center
at S, the chirality of which depends on which lone pair is involved [87].
Visually this manifests itself in the direction that the Cε methyl group
points. If the smallest angle from Cγ to Cε about Sδ (viewed from the
Met side, perpendicular to the plane of the heme) is going clockwise
fromCγ to Cε, the chirality is S. If counterclockwise, it isR. mitochondrial
cyt c and alphaproteobacterial cyt c2 have R chirality. It is now pretty
clear that it is S in cyt c1, based on most recent and highest resolution
structures from yeast (3cx5), beef (1ppj, 2fyu), or chicken (3L70). How-
ever some of the pioneering structures (e.g. 1be3, 1L0n) had it the other
way, perhaps due to using cyt c as a model and for topology and
parameters.
8. Conclusions
Synthesizing the crystallographic results for cytochrome bc1 from
a number of different crystal forms in the presence of various inhibi-
tors presents a more complete picture of the structure than any onecrystal form could have provided, and also provides warning of possi-
ble uncertainty when the structures disagree. This approach would be
even more powerful if diffraction data were made available for all of
the structures.
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